Prevention of GVHD without losing GVL effect: windows of opportunity (Q37817036)

23 August 2017

1 reference

title

Prevention of GVHD without losing GVL effect: windows of opportunity (English)

1 reference

23 August 2017

3

Nelson J Chao

1 reference

23 August 2017

Ping Zhang

1

1 reference

23 August 2017

Benny J Chen

series ordinal

2

1 reference

23 August 2017

publication date

1 April 2011

1 reference

23 August 2017

1 reference

23 August 2017

volume

49

1 reference

23 August 2017

issue

1-3

1 reference

23 August 2017

page(s)

49-55

1 reference

Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Effects of interleukin-11 on carboplatin-induced thrombocytopenia in rats and in combination with stem cell factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-010-8193-7

Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL

21 January 2018

1 reference

12 December 2020

Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ

1 reference

12 December 2020

Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants

1 reference

12 December 2020

Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings

1 reference

12 December 2020

Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses

1 reference

12 December 2020

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease

1 reference

12 December 2020

Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease

1 reference

12 December 2020

Treatment of mouse lymphosarcoma by total-body x-irradiation and by injection of bone marrow and lymph-node cells

1 reference

12 December 2020

Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial

1 reference

12 December 2020

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1 reference

12 December 2020

Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.

1 reference

12 December 2020

Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

1 reference

12 December 2020

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

12 December 2020

Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype

1 reference

12 December 2020

Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia

1 reference

12 December 2020

A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients

1 reference

12 December 2020

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

12 December 2020

Delayed lymphocyte infusion in children given SCT

1 reference

12 December 2020

The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings

1 reference

12 December 2020

[Trial therapy, by x-irradiation followed by the administration of homologous bone marrow cells, of highly-advanced spontaneous leukemia in AK mice.]

1 reference

12 December 2020

Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant

1 reference

12 December 2020

T cell subsets and graft-versus-host disease

1 reference

12 December 2020

Memory CD4+ T cells do not induce graft-versus-host disease

1 reference

12 December 2020

Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

10.1007/S12026-010-8193-7

Identifiers

DOI

1 reference

23 August 2017

1 reference